Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 7/20 | 0.42 |
| ▸ | CES1 | P23141 | 5/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 6/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1697656 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL83980 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL4854234 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL23034519 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL11245966 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL24234728 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL465782 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL6934289 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL22268768 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL4434277 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 344 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0003663-A2 | Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them | AMERICAN CYANAMID COMPANY (US) | 1979-08-22 | — | — | EP | claimed |
| EP-4074807-B1 | COMPOSITIONS COMPRISING A FLUOROOLEFIN | CHEMOURS CO FC LLC (US) | 2025-07-09 | — | — | EP | disclosed |
| EP-3543310-B2 | COMPOSITIONS COMPRISING HFC-1234YF AND HFC-32 | CHEMOURS CO FC LLC (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-3299435-B1 | METHOD OF PREPARING A COMPOSITION COMPRISING HFC-1234YF | CHEMOURS CO FC LLC (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-3309233-B2 | COMPOSITIONS COMPRISING HFC-1234YF AND HFC-152A | CHEMOURS CO FC LLC (US) | 2024-02-21 | — | — | EP | disclosed |
| EP-2749623-B2 | Method for replacing a high GWP refrigerant in a refrigeration, air-conditioning, or heat pump apparatus | CHEMOURS CO FC LLC (US) | 2024-02-21 | — | — | EP | disclosed |
| US-20230265330-A1 | COMPOSITIONS COMPRISING A FLUOROOLEFIN | THE CHEMOURS COMPANY FC, LLC (US) | 2023-08-24 | — | — | US | disclosed |
| US-11674067-B2 | Compositions comprising a fluoroolefin | THE CHEMOURS COMPANY FC, LLC (US) | 2023-06-13 | — | — | US | disclosed |
| US-20220389298-A1 | COMPOSITIONS COMPRISING A FLUOROOLEFIN | THE CHEMOURS COMPANY FC, LLC (US) | 2022-12-08 | — | — | US | disclosed |
| US-20220389297-A1 | COMPOSITIONS COMPRISING A FLUOROOLEFIN | THE CHEMOURS COMPANY FC, LLC (US) | 2022-12-08 | — | — | US | disclosed |
| CN-1008091-B | Process for preparing leukotriene antagonists | SMITHKLINE BECKMAN CORP (US) | 1990-05-23 | — | — | CN | disclosed |
| CN-1040586-A | Process for preparing leukotriene antagonists | SMITHKLINE BECKMAN CORP (US) | 1990-03-21 | — | — | CN | disclosed |
| CN-86102482-A | Process for preparing leukotriene antagonists | — | 1987-02-04 | — | — | CN | disclosed |
| CN-85100811-A | The antagonistic preparation method of leukotriene | — | 1986-07-09 | — | — | CN | disclosed |
| US-4318914-A | Hypolipidemic and antiatherosclerotic 4-(polyfluoro-alkylamino)phenyl compounds | AMERICAN CYANAMID COMPANY (US) | 1982-03-09 | — | — | US | disclosed |
| US-4310545-A | Hypolipidemic and antiatherosclerotic 4-(polyfluoroalkylamino) phenyl compounds | AMERICAN CYANAMID COMPANY (US) | 1982-01-12 | — | — | US | disclosed |
| US-4305959-A | Hypolipidemic and antiatherosclerotic 4-(polyfluoro-alkylamino)phenyl compounds | AMERICAN CYANAMID COMPANY (US) | 1981-12-15 | — | — | US | disclosed |
| US-4205085-A | Hypolipidemic and antiatherosclerotic 4-(polyfluoroalkylamino)phenyl compounds | AMERICAN CYANAMID COMPANY (US) | 1980-05-27 | — | — | US | disclosed |
| US-4147884-A | Liquid phase oxidation of unsaturated aldehydes to corresponding acids | ATLANTIC RICHFIELD COMPANY (US) | 1979-04-03 | — | — | US | disclosed |
| US-3932318-A | COPOLYMERS WITH ISOCYANATES, CRYOGENIC POLYMERIZATION, NONFLAMMABLE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-01-13 | — | — | US | disclosed |